Find Imofinostat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Mpt0e028, 1338320-94-7, T65l58fi65, (e)-3-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-n-hydroxyprop-2-enamide, 2-propenamide, 3-(2,3-dihydro-1-(phenylsulfonyl)-1h-indol-5-yl)-n-hydroxy-, Imofinostat
Molecular Formula
C17H16N2O4S
Molecular Weight
344.4  g/mol
InChI Key
MGTIFSBCGGAZDB-VQHVLOKHSA-N
FDA UNII
T65L58FI65

Imofinostat
Imofinostat is an orally bioavailable N-hydroxyacrylamide-derived inhibitor of both human pan-histone deacetylase (HDAC) enzymes and the serine/threonine protein kinase Akt (protein kinase B), with potential antineoplastic activity. Upon administration, imofinostat selectively binds to and inhibits HDACs, which inhibits deacetylation of histone proteins and leads to the accumulation of highly acetylated histones. This may result in both an induction of chromatin remodeling, and the selective transcription of tumor suppressor genes. This prevents cell division and induces both cell cycle arrest and apoptosis, which may inhibit the proliferation of susceptible tumor cells. In addition, imofinostat inhibits the phosphorylation and activation of Akt, which prevents the activation of downstream signaling pathways, independent of its HDAC inhibitory activity. HDACs, upregulated in many tumor cell types, are a family of enzymes that deacetylate histone proteins. Akt, overexpressed in many tumor cell types, plays a key role in tumor cell proliferation and survival.
1 2D Structure

Imofinostat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(E)-3-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-N-hydroxyprop-2-enamide
2.1.2 InChI
InChI=1S/C17H16N2O4S/c20-17(18-21)9-7-13-6-8-16-14(12-13)10-11-19(16)24(22,23)15-4-2-1-3-5-15/h1-9,12,21H,10-11H2,(H,18,20)/b9-7+
2.1.3 InChI Key
MGTIFSBCGGAZDB-VQHVLOKHSA-N
2.2 Other Identifiers
2.2.1 UNII
T65L58FI65
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Mpt0e028

2. 1338320-94-7

3. T65l58fi65

4. (e)-3-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-n-hydroxyprop-2-enamide

5. 2-propenamide, 3-(2,3-dihydro-1-(phenylsulfonyl)-1h-indol-5-yl)-n-hydroxy-

6. Imofinostat

7. Unii-t65l58fi65

8. Imofinostat [inn]

9. Orb1706952

10. Schembl2511433

11. Mgtifsbcggazdb-vqhvlokhsa-n

12. Glxc-04031

13. Akos040742169

14. Ms-25283

15. Sy461501

16. Hy-124295

17. Cs-0086144

18. G16985

19. Q27289720

20. (e)-n-hydroxy-3-[1-(phenylsulfonyl)indolin-5-yl]acrylamide

21. (2e)-3-[1-(benzenesulfonyl)-2,3-dihydro-1h-indol-5-yl]-n-hydroxyprop-2-enamide

2.4 Create Date
2011-10-31
3 Chemical and Physical Properties
Molecular Weight 344.4 g/mol
Molecular Formula C17H16N2O4S
XLogP31.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area95.1
Heavy Atom Count24
Formal Charge0
Complexity578
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty